Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Compass Therapeutics, Inc. (CMPX) had Normalized Pre-Tax Income of $-15.72M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-15.72M |
|
-- |
|
-- |
|
$17.99M |
|
$-17.99M |
|
$2.27M |
|
$-15.72M |
|
|
Normalized Pre-Tax Income |
$-15.72M |
$-15.72M |
|
$-15.72M |
|
$-15.72M |
|
$-15.72M |
|
$-17.99M |
|
$-18.82M |
|
157.69M |
|
157.69M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$209.82M |
|
$0.10M |
|
$9.77M |
|
$219.59M |
|
$13.97M |
|
-- |
|
$8.83M |
|
$22.80M |
|
$196.79M |
|
$196.79M |
|
$196.79M |
|
178.32M |
|
| Cash Flow Statement Financials | |
$-49.14M |
|
$-93.31M |
|
$129.61M |
|
$44.05M |
|
$31.21M |
|
$-12.84M |
|
$8.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.99% |
|
-7.99% |
|
-7.16% |
|
-7.99% |
|
$1.10 |
|
$-0.31 |
|
$-0.31 |
|